In vivo antipyretic, antiemetic, in vitro membrane stabilization, antimicrobial, and cytotoxic activities of different extracts from Spilanthes paniculata leaves

BACKGROUND: The study was conducted to evaluate the in vitro antimicrobial activity, cytotoxic, and membrane stabilization activities, and in vivo antiemetic and antipyretic potentials of ethanolic extract, n-hexane and ethyl acetate soluble fractions of Spilanthes paniculata leaves for the first time widely used in the traditional treatments in Bangladesh. RESULTS: In antipyretic activity assay, a significant reduction (P < 0.05) was observed in the temperature in the mice tested. At dose 400 mg/kg-body weight, the n-hexane soluble fraction showed the effect (36.7 ± 0.63°C ) as like as the standard (dose 150 mg/kg-body weight) after 5 h of administration. Extracts showed significant (P < 0.001) potential when tested for the antiemetic activity compared to the standard, metoclopramide. At dose 50 mg/kg-body weight, the standard showed 67.23% inhibition, whereas n-hexane and ethyl acetate soluble fractions showed 37.53% and 24.93% inhibition of emesis respectively at dose 400 mg/kg-body weight. In antimicrobial activity assay, the n-hexane soluble fraction (400 µg/disc) showed salient activity against the tested organisms. It exerts highest activity against Salmonella typhi (16.9 mm zone of inhibition); besides, crude, and ethyl acetate extracts showed resistance to Bacillus cereus and Bacillus subtilis, and Vibrio cholera respectively. All the extracts were tested for lysis of the erythrocytes. At the concentration of 1mg/ml, ethanol extract, and n-hexane and ethyl acetate soluble fractions significantly inhibited hypotonic solution induced lysis of the human red blood cell (HRBC) (27.406 ± 3.57, 46.034 ± 3.251, and 30.72 ± 5.679% respectively); where standard drug acetylsalicylic acid (concentration 0.1 mg/ml) showed 77.276 ± 0.321% inhibition. In case of heat induced HRBC hemolysis, the plant extracts also showed significant activity (34.21 ± 4.72, 21.81 ± 3.08, and 27.62 ± 8.79% inhibition respectively). In the brine shrimp lethality bioassay, the n-hexane fraction showed potent (LC50 value 48.978 µg/ml) activity, whereas ethyl acetate fraction showed mild (LC50 value 216.77 µg/ml) cytotoxic activity. CONCLUSIONS: Our results showed that the n-hexane extract has better effects than the other in all trials. In the context, it can be said that the leaves of S. paniculata possess remarkable pharmacological effects, and justify its folkloric use as antimicrobial, antipyretic, anti-inflammatory, and antiemetic agent. Therefore, further research may be suggested to find possible mode of action of the plant part.

Antibacterial & antitoxic effects of the cardiovascular drug lacidipine in an animal model.

Background & objectives: Vibrio cholerae produces acute infection by liberating potent enterotoxin, called cholera toxin in human intestine. Cardiovascular drug lacidipine possessing powerful in vitro action against V. cholerae was tested to determine its possible activity against a toxigenic V. cholerae strain in an established animal model. Methods: In the rabbit intestine four loops were constructed, 3 of which were injected with over night grown V. cholerae 569B culture. Of these, two loops were simultaneously given graded doses (100, 200 μg) of lacidipine, one was left as such for a positive control. The first loop received sterile medium (negative control). After 18 h, contents of all the loops were examined for accumulation of fluid and number of viable cells. Results: Lacidipine when administrated with live V. cholerae 569B, caused a reduction in the number of viable bacteria along with amount of fluid in the loops. The amount of fluid and number of viable cells were much reduced in the loop that had 200 μg of lacidipine than the loop that received 100 μg of the drug. Interpretation & conclusions: Lacidipine has distinct inhibitory action against V. cholerae 569B with respect to both viability and production of cholera toxin in the rabbit ileum. Structural modifications of this compound may possibly lead to procurement of new potent antimicrobial drugs.

SXT constin among Vibrio cholerae isolates from a tertiary care hospital.

Background & objectives: The SXT element, also known as ‘constin’ (conjugable, self transmissible, integrating element) is an integrating conjugative element (ICE) in Vibrio cholerae discovered in the chromosome of epidemic V. cholerae O139 strain MO10 (SXTMO10) which arose in late 1992 in Chennai, India. SXT related ICEs have become widespread and currently, most if not all Asian V. cholerae clinical isolates contain SXT related ICEs. The present study attempts to determine the presence of SXT Int gene in V. cholerae recovered between 2005 to 2007 in a tertiary care hospital, demonstrate its conjugal nature and also detect co-presence and co-transfer of plasmids in representative isolates. Methods: This prospective study was done on 116 V. cholerae isolates [114- O1 (107 ogawa and 7 inaba) and 2 - Non O1 Non O139 V. cholerae] from watery stools between 2005 to 2007 recovered from equal number of patients. PCR was carried out using SXT Int specific primers that produced a 592 bp internal fragment of SXT element, and rifampicin resistant strain of E.coli K-12 was used as recipient in conjugation experiments to study transfer of SXT, as also co-transfer of resistance to tetracycline, erythromycin, and nalidixic acid. Antibiotic susceptibility was performed against various antibiotics. Results: Of the 116 isolates, 110 (94.8%) were positive for SXT element by PCR. It was demonstrated in 94.7 per cent of the O1, and 100 per cent of non O1 non O139 V. cholerae. All 2005 isolates, 25 per cent of 2006 isolates and 96.6 per cent of 2007 isolates were positive for SXT. Thirty two drug resistance patterns were observed and the 2007 isolates showed resistance to as many as eight antibiotics. The resistance of SXT positive isolates was higher than those of SXT negative and the typical drug resistance pattern corresponding to SXTET and SXTMO10 was shown by only one V. cholerae O1 isolate. Successful conjugal transfer of SXT was seen in 31 (88.6%) of the 35 isolates studied without any co-transfer while, presence of plasmids was observed in two of the 31 donor V. cholerae studied. Interpretation & Conclusions: The demonstration of SXT element and its successful horizontal transfer in V. cholerae isolates studied emphasizes the need for its detection to monitor antibiotic resistance and dissemination in V. cholerae.

Inhibition of virulence potential of Vibrio cholerae by natural compounds.

The rise in multi-drug resistant Vibrio cholerae strains is a big problem in treatment of patients suffering from severe cholera. Only a few studies have evaluated the potential of natural compounds against V. cholerae. Extracts from plants like ‘neem’, ‘guazuma’, ‘daio’, apple, hop, green tea and elephant garlic have been shown to inhibit bacterial growth or the secreted cholera toxin (CT). However, inhibiting bacterial growth like common antimicrobial agents may also impose selective pressure facilitating development of resistant strains. A natural compound that can inhibit virulence in V. cholerae is an alternative choice for remedy. Recently, some common spices were examined to check their inhibitory capacity against virulence expression of V. cholerae. Among them methanol extracts of red chili, sweet fennel and white pepper could substantially inhibit CT production. Fractionation of red chili methanol extracts indicated a hydrophobic nature of the inhibitory compound(s), and the n-hexane and 90 per cent methanol fractions could inhibit >90 per cent of CT production. Purification and further fractionation revealed that capsaicin is one of the major components among these red chili fractions. Indeed, capsaicin inhibited the production of CT in various V. cholerae strains regardless of serogroups and biotypes. The quantitative reverse transcription real-time PCR assay revealed that capsaicin dramatically reduced the expression of major virulence-related genes such as ctxA, tcpA and toxT but enhanced the expression of hns gene that transcribes a global prokaryotic gene regulator (H-NS). This indicates that the repression of CT production by capsaicin or red chili might be due to the repression of virulence genes transcription by H-NS. Regular intake of spices like red chili might be a good approach to fight against devastating cholera.

Antimicrobials & cholera: are we stranded.

Antimicrobial resistance poses a major threat in the treatment of infectious diseases. Though significant progress in the management of diarrhoeal diseases has been achieved by improved hygiene, development of new antimicrobials and vaccines, the burden remains the same, especially in children below 5 yr of age. In the case of cholera, though oral rehydration treatment is the mainstay, antimicrobial therapy is mandatory at times to reduce the volume of stool and shorten the duration of the disease. Though for many pathogens, antimicrobial resistance emerged soon after the introduction of antibiotics, Vibrio cholerae remained sensitive to most of the antibiotics for quite a long period. However, the scenario changed over the years and today, V. cholerae strains isolated world over are resistant to multiple antibiotics. A myriad number of mechanisms underlie this phenomenon. These include production of extended-spectrum beta-lactamases, enhanced multi-drug efflux pump activity, plasmid-mediated quinolone and fluoroquinolone resistance, and chromosomal mutations. Horizontal transfer of resistance determinants with mobile genetic elements like integrons and the integrating conjugative elements (ICEs), SXTs help in the dissemination of drug resistance. Though all strains isolated are not resistant to all antibiotics and we are not as yet “stranded”, expanding spectrum of drug resistance is a definite cause for concern. Pipelines of discovery of new antibiotics are drying up as major pharmaceutical companies are losing interest in investing money in this endeavour, mainly due to the short shelf-life of the antibiotics and also due to the fast emergence of drug resistance. To address this issue, attempts are now being made to discover drugs which are pathogen specific and target their “virulence mechanisms”. It is expected that development of resistance against such antibiotics would take much longer. This review briefly focuses on all these issues.

Antibacterial effect (in vitro) of Moringa oleifera and Annona muricata against Gram positive and Gram negative bacteria / Efeito antibacteriano (in vitro) de Moringa oleifera (moringa) e Annona muricata (graviola) frente a bactérias Gram-negativas e Gram-positiva

Antibacterial effects of aqueous and ethanolic extracts of seeds of moringa (Moringa oleifera) and pods of soursop (Annona muricata) in the concentration of 1:5 and 1:10 in volumes 50, 100, 150 and 200 µL were examined against Staphylococcus aureus, Vibrio cholerae, Escherichia coli (isolated from the organism and the aquatic environment) and Salmonella Enteritidis. Antibacterial activity (inhibition halo > 13 mm) against S. aureus, V. cholerae and E. coli isolated from the whiteleg shrimp, Litopenaeus vannmaei, was detected in aqueous and ethanolic extracts of moringa. E. coli isolated from tilapiafish, Oreochromis niloticus, was sensitive to the ethanolic extract of moringa. The aqueous extracts of soursop showed an antibacterial effect against S. aureus and V. cholerae, but the antibacterial activity by the ethanol extracts of this plant was not demonstrated.

Para avaliação do efeito bactericida frente à Staphylococcus aureus, Vibrio cholerae, Escherichia coli (isolada de pescados e ambiente aquático) e Salmonella Enteretidis, foram testados extratos aquosos e etanólicos de sementes de moringa (Moringa oleifera) e casca de graviola (Annona muricata) na concentração de 1:5 e 1:10, nos volumes de 50, 100, 150 e 200 µL. Os resultados mostraram efeito antibacteriano (halo de inibição > 13mm) dos extratos aquosos e etanólicos de moringa frente a S. aureus, V. cholerae e E. coli isoladas de camarão cinza Litopenaeus vannmaei. A cepa de E. coli isolada do pescado Oreochromis niloticus apresentou sensibilidade frente ao extrato etanólico de moringa. Os extratos aquosos de graviola apresentaram efeito bactericida frente a S. aureus e V. cholerae, entretanto, os extratos etanólicos dessa planta não mostraram atividade antibacteriana.

Occurrence and composition of class 1 and class 2 integrons in clinical and environmental O1 and non-O1/non-O139 Vibrio cholerae strains from the Brazilian Amazon

This study identified and characterised class 1 and 2 integrons in clinical and environmental Vibrio cholerae O1 and non-O1/non-O139 strains isolated from the Brazilian Amazon. The aadA2 and aadA7 gene cassettes were found in class 1 integrons in two genotypes of environmental V. cholerae non-O1/non-O139. Empty integrons were found in strains from the Brazilian cholera epidemic. A class 2 integron was detected in one strain from the V. cholerae Amazonia lineage harbouring sat1 and aadA1 genes. All isolates were resistant to aminoglycosides, indicating aadA functionality. These findings suggest that environmental bacteria act as cassette reservoirs that favour the emergence of resistant pathogens.

Changing characteristics of Vibrio cholerae: emergence of multidrug resistance and non-O1, non-O139 serogroups.

The serogroups and antimicrobial susceptibility patterns of V. cholerae isolated in Hubli, India during the years 2000 to 2004 were monitored. A total of 256 V. cholerae isolates were obtained during the study period, of which 129 (50.4%) belonged to serogroup O1 while the O139 and non-O1, non-O139 serogroups constituted 61 (23.8%) and 66 (25.8%) isolates, respectively. V. cholerae O1 Ogawa was the predominant isolate during the first 2 years of the study. However, this was replaced by V. cholerae non-O1, non-O139 serogroups in the following years. The V. cholerae, which was susceptible to most enteric antimicrobials in 2000, was found to be multidrug resistant in subsequent years, with the development of fluroquinolone resistance since 2002. Surveillance of the epidemiological and microbiological characteristics of V. cholerae provides useful information for managing cholera cases. The V. cholerae non-O1, non-O139 serogroups coupled with multiple antimicrobial resistance may form a group of emerging diarrheal pathogens in the tropics.

Pathogenicity, antibiotic susceptibility and genetic similarity of environmental and clinical isolates of Vibrio cholerae.

Isolates of Vibrio cholerae were obtained from clinical and environmental samples and the pathogenicity of these isolates was confirmed by hemolytic assay. The clinical isolates were more pathogenic than environmental isolates. Antibiotic susceptibility of V. cholerae to a set of antibiotics showed a marked variation. The environmental isolates exhibited more resistance to the antibiotics than clinical isolates. The plasmid curing technique was used to check the encoding of antibiotic resistance gene in genome. In both isolates, the resistance to vancomycin and co-trimaxazole was not mediated by plasmid and it may probably be encoded in genome. RAPD method was adopted to find out the variation in the genome of the clinical isolates and environmental isolates of V. cholerae. The genomic similarity pattern revealed that the environmental Ogawa isolates were closely related to clinical Ogawa isolates. This study confirmed the existence of the complex nature of V. cholerae in its pathogenicity, response to a set of antibiotics and genetic similarity.

Antimicrobial resistance of clinical and environmental strains of Vibrio cholerae isolated in Lima-Peru during epidemics of 1991 and 1998

The susceptibility in vitro of 71 isolations of V. cholerae was evaluated: 24 of clinical origin and 47 strains of clinical and environmental origin collected in the epidemic of 1991 and during the outbreak epidemic of 1998 in Lima-Peru respectively. The biochemical and serological tests carried out established that 43 (60,6 percent) corresponded to the serogroup O1 Ogawa of the 1998 epidemic; 26 (36.6 percent) were of the serotype Inaba, being 24 of them isolated in 1991. Two strains did not belong to the serogroup O1. By means of disk diffusion method and Minimal Inhibitory Concentration (MIC), 15 strains with multi-resistance to antibiotics were determined, 10 of which were of clinical origin and 5 of natural origin, showing 9 antibiotypes with different resistance pattern. The evaluation of susceptibility in front of the vibriostatic agent O/129, demonstrated that 11.4 percent of the strains, collected in 1998, presented resistance to a concentration of 150 æg. A direct relationship among the resistance that presented the strains of clinical and environmental origin isolated in 1991 and 1998 was established as much for tetracycline, sulfa/trimethoprim and 0/129; 88.6 percent of the clinical strains of the year 1998 presented resistance to these three drugs, while 100 percent of clinical strains isolated in 1991 were sensitive to O/129 (150 µg), sulfa/trimethoprim and tetracycline. We conclude that V. cholerae O1 has increased its resistance to antimicrobial drugs of clinical use in the same way it is also losing susceptibility to the vibriostatic compound O/129 for what their use is not recommended for taxonomic purposes.

Isolation and antibiotic susceptibility pattern of vibrio cholerae in children

Laboratory diagnosis of Vibrio cholerae in children with its susceptibility pattern to different antibiotics. 460 patients aged from few days and up to 12 years were included in this study. These children were admitted to Nahrin teaching hospital in June 1999 due to sudden onset of watery diarrhea that led to various degrees of dehydration. Full examination of each patient was done to assess the degree of dehydration. Stool examinations were done macroscopically followed by culture of the stool in selective media for Vibrio called Thiosulfate-Citrate-Bile-Sucrose [TCBS]. A further identification by biochemical and serological test was done to confirm the diagnosis. Antibiotic susceptibility tests to different antibiotics were done to every case. -according to the degree of dehydration, these 460 patients were divided into 4 groups, of which 47.8% had sever dehydration, 40% had moderate dehydration, 9.1% had mild dehydration and only 3% were not dehydrated. On macroscopical stool examination 90% were watery in consistency with 2.6% contain blood and mucus. Out of these 460 cases having diarrhea, 160 cases [34.8%] were diagnosed as cholera cases, of which 54.4% were males and 45.6% were females. The percentage according to age of the patients were 16.3% < 1 year of age, 62.5% of 1-5 years and 21.3% > 5 years. Regarding residency of the patients, the highest percent were, from Al-Mahmoodyiah district [37.5%] followed by Abu-Graib district [20%]. In addition to dehydration, 50% of the admitted patients had vomiting, 31% had fever which presented mainly in children below 5 years of age, 3% of the cases developed convulsion and 4.4% had stupor. Antibiotic susceptibility tests were done using the following antibiotics and their percentage of sensitivity as follows, Ampicillin [49%], Tetracycline [4.9%], Gentamycin [31%], Trimetheprim [68.4%], Erythromycin [38.5%] and Nalidixic acid [69.4%]. -Vibrio cholerae is one of the important causes of watery diarrhea that lead to sever dehydration and various complications if untreated. In children, the highest percent of the disease is in patients of 1-5 years of age with the highest percent in people living in the periphery of Baghdad. The microorganisms show high resistance rate to commonly used antibiotic such as Tetracycline

First report of Vibrio cholerae infection from Andaman and Nicobar, India.

Out of 34 Stool Samples collected during an outbreak of diarrhoea, Vibrio cholerae 01 was isolated from 10 samples contrary to earlier reports that Shigella species was the only cause of diarrhoeal disease in Andaman & Nicobar Islands.

Características de la epidemia de cólera de 1998 en Ecuador, durante el fenómeno de "El Niño" / Characteristics of the cholera epidemic of 1998 in Ecuador during El Niño

Objetivos. Caracterizar el brote de cólera ocurrido en Ecuador en 1998 durante el fenómeno de "El Niño", presentar los datos sobre la resistencia de las cepas circulantes de Vibrio cholerae a los antimicrobianos y describir las medidas preventivas tomadas por las autoridades sanitarias para reducir el impacto de la enfermedad. Métodos. Los datos epidemiológicos provienen de los registros de la Dirección Nacional de Epidemiología del Ministerio de Salud Pública de Ecuador y del Instituto Nacional de Higiene y Medicina Tropical, y el informe final del Programa de Formación para la Lucha contra el Cólera y las Enfermedades Diarreicas (PROCED ALA 93/25). Se procedió a aislar, identificar y serotipificar V. cholerae en las muestras de heces de 10 por ciento de los pacientes con posible cólera identificados entre el 1 de enero y el 31 de diciembre de 1998. Los casos sospechados se definieron por la aparición súbita de diarrea acuosa, con o sin deshidratación, en zonas epidémicas. Las cepas aisladas se sometieron a un antibiograma estándar por el método de difusión, en el que se probaron los siguientes antibióticos: amoxicilina, tetraciclina, sulfametoxazol con trimetoprim, compuesto vibriostático O/129, ácido nalidíxico, eritromicina, norfloxacino, ciprofloxacino, gentamicina, cloranfenicol y colistina. Resultados. En 1998 se notificaron 3 755 casos en 17 de las 21 provincias del país, lo que corresponde a una tasa de incidencia de 53,96 por 100 000 habitantes. Treinta y siete pacientes fallecieron, lo cual supone una tasa de letalidad del 0,97 por ciento. Se aislaron 301 cepas de V. cholerae en las 637 muestras con sospechosa de cólera que se procesaron; todas correspondieron a V. cholerae O:1, El Tor, subtipo Ogawa. La totalidad de las cepas fueron sensibles a la tetraciclina y a las quinolonas, y 5,6 por ciento resistentes a la eritromicina. La única cepa resistente a la amoxicilina fue multirresistente. Las autoridades nacionales pusieron en práctica una serie de medidas preventivas en la comunidad y se fortaleció el sistema de vigilancia para reducir el impacto de la enfermedad. Conclusiones. Las medidas preventivas contribuyeron a reducir el impacto de la nueva epidemia de cólera en el Ecuador, tanto en términos de letalidad como de incidencia

Synergistic effect of ayurvedic pearl preparation on enhancing effectiveness of antibiotics.

Studies were carried out with ayurvedic preparations derived from pearl, which include preparations bhasma and pishti. The synergistic effect to reduce the dose of antibiotic was tested against E. coli the test bacterium with ampicillin antibiotic by bore well and disks diffusion methods. It was observed that pearl preparations do not show any antibacterial activity but when used at 200 microg/ml concentration with antibiotics, then even at sub-lethal dose, the antibiotic has effectively shown the results with reduced contact time. The protocol was also tested with the other bacteria like, Pseudomonas aeruginosa. Vibrio cholarae, Salmonella typhi, and Staphylococcus aureus and has shown similar results. The pearl bhasma synergistic effect was also tested with other antibiotics such as erythromycin, kanamycin, and ampicillin.

Transition of drug susceptibilities of Vibrio cholerae O1 in Lao People's Democratic Republic.

The changes of drug susceptibilities of Vibrio cholerae O1 isolated during the past 7 years (1993-1999) in Lao PDR were investigated. The most noteworthy finding was the appearance of polymyxin B sensitive El Tor vibrios. Until 1996, the susceptibilities were almost as expected and cholera disappeared in 1997. When a cholera outbreak resurfaced in 1998, the susceptibilities of isolated V. cholerae O1 against tetracycline, sulfamethoxazol-trimethoprim, chloramphenicol and polymyxin B were quite different from those of previously isolated organisms. Minimum inhibitory concentrations (MICs) of tetracycline and chloramphenicol against the isolates in 1998 were about 16 times higher than those against the previous isolates, and the MICs of sulfamethoxazol-trimethoprim were about 256 times higher than those against the previous isolates, (trimethoprim 32 microg/ml: sulfamethoxazol 608 microg/ml). Eleven percent of the isolates (11/99) were as sensitive to polymyxin B as the classic cholera vibrios (MIC < 2 microg/ml). In 1999, the susceptibility pattern was almost the same as that in 1998 except for polymyxin B to which 58% of the isolates (21/36) became sensitive.

Vibrio cholerae resistant to 2,4-diamino-6,7-diisopropylpteridine (O/129) isolated from patients with enteritis in Ceará, Brazil.

This paper reports the characterization of clinical Vibrio cholerae resistant to vibriostatic agent O/129, using classical and plasmid analysis. In a study conducted during December 1991-September 1993, two of 7,058 V. cholerae strains, obtained from patients suspected to have cholera in the State of Ceará, northeast Brazil, were resistant to 150 micrograms of the vibriostatic agent O/129 (2,4-diamino-6,7-diisopropylpteridine). One strain was identified as V. cholerae O1 El Tor Inaba and the other one as serogroup O22. Only one O1 strain harboured a plasmid of 147 kb transferable to Escherichia coli K12, and five strains of V. cholerae O1 and non-O1 were sensitive to O/129 and plasmid-negative at a frequency between 8 x 10(-2) and 3.6 x 10(-5). Additionally, O/129-resistant strains of V. cholerae O1 and O22 were resistant to trimethoprim/sulphamethoxazole.

An outbreak of Eltor cholera in Aizwal town of Mizoram, India.

During the months of May, June and through early part of July 1994, an unusual occurrence of severe dehydrating watery diarrhoea cases and deaths were reported from Aizwal town, the capital of Mizoram, a North-Eastern state of India. Vibrio cholerae 01 biotype Eltor, the causative agent responsible for this outbreak, was isolated from 50.0% of hospitalised cases. The disease affected older children and adults more (52.9%) than younger children below five years of age. Vibrio cholerae 01 strains isolated were uniformly resistant to furazolidone and co-trimoxazole, which are commonly advocated in the treatment of cholera specially in children of developing countries. Emergence of such resistant strain is alarming and is of great public health importance.

Vigilancia en red de los serotipos y la susceptibilidad antimicrobiana de Salmonella spp., Shigella spp. y Vibrio cholerae 01, 1997 -1999 / Surveillance of serotypes and antimicrobial susceptibility of Salmonella spp., Shigella spp. and Vibrio cholerae 01, 1997-1999

En 1997, el Grupo de Microbiología del INS estableció un programa en red con los Laboratorios de Salud Pública (LSP) del país y el apoyo de la OPS, para la vigilancia de los principales patógenos causantes de enfermedad diarreica aguda. El objetivo fue conocer los serotipos y los patrones de resistencia antimicrobiana de Salmonella spp., Shigella spp. y Vibrio cholerae 01. Los aislamientos fueron confirmados de acuerdo con los esquemas de identificación bioquímica y serológica estandarizados y la determinación de la susceptibilidad antimicrobiana se realizó por la técnica de difusión de disco (Kirby-Bauer). De 1997 a 1999, participaron 22 LSP con el envió de 976 aislamientos, 96 por ciento de origen clínico y 4 por ciento de alimentos; 34 por ciento Salmonella spp., 23 por ciento Shigella spp. y 42 por ciento V. cholerae 01. La distribución por serotipo de Salmonella fue 39 por ciento S. enteriditis, 27 por ciento S. Typhimurium, 9 por ciento grupo E1,5 por ciento S. typhi y 20 por ciento otros serotipos; de los aislamientos de Shigella, 67 por ciento fueron S. grupo flexneri 2a, 30 por ciento S. sonnei, 2 por ciento S dysenteriae y 1 por ciento S. boydii. Para V. cholerae 01, 99 por ciento fue serotipo Ogawa. La susceptibilidad antimicrobiana determinó que 56 por ciento de los aislamientos de Salmonella eran resistentes y 22 por ciento multiresistentes, con un patrón predominante de ampicilina, tetraciclina y trimetoprim-sulfa (SXT). De los aislamientos de Shigella, 97 por ciento fueron resistentes y 57 por ciento multirresistentes, con un patrón de ampicilina , tetraciclina, cloranfenicol y SXT. No se observaron cambios en la susceptibilidad de V. cholerae 01. Este estudio enfatiza la importancia de continuar con el programa de vigilancia, para conocer la epidemiología de la EDA en Colombia, darle un tratamiento óptimo a estas infecciones y poder diseñar programas para diseñar programas para disminuir la diseminación de bacterias resistentes